What Happened?
London, -based GyroscopeTX Resigned Alexis Bloom as Senior Vice President and Head of Regulatory Affairs and Quality Assurance
About the Company
Gyroscope Therapeutics is a clinical-stage gene therapy company developing gene therapy beyond rare disease to treat diseases of the eye that cause vision loss and blindness. The company was acquired by Novartis, a leading global medicines company, in February 2022.
About the Person
Alexis Bloom is Senior Vice President and Head of Regulatory Affairs and Quality Assurance at Gyroscope Therapeutics. Previously, Alexis held various senior legal leadership roles in the industry.
Info Source
News
Short Profile